HRMY - Harmony Biosciences Holdings Inc
IEX Last Trade
36.005
0.255 0.708%
Share volume: 168,747
Last Updated: Fri 30 Aug 2024 09:59:49 PM CEST
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
0.87%
PREVIOUS CLOSE
CHG
CHG%
$35.75
0.26
0.71%
View ratios
| Fiscal Date | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 | 2024-03-31 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | |
| Report Date | 2022-08-02 | 2022-11-01 | 2023-02-21 | 2023-05-02 | 2023-08-01 | 2023-10-31 | 2024-02-22 | 2024-04-30 | |
| Total revenue | 107.028 M | 117.206 M | 128.308 M | 119.126 M | 134.216 M | 160.268 M | 168.412 M | 154.615 M | |
| Cost of revenue | 18.921 M | 22.959 M | 26.885 M | 20.780 M | 25.008 M | 32.296 M | 43.152 M | 27.484 M | |
| Gross profit | 88.107 M | 94.247 M | 101.423 M | 98.346 M | 109.208 M | 127.972 M | 125.260 M | 127.131 M | |
| 6.97% | 7.61% | -3.03% | 11.04% | 17.18% | -2.12% | 1.49% | |||
| Operating expenses | 54.991 M | 82.346 M | 53.810 M | 57.923 M | 62.306 M | 63.463 M | 85.064 M | 75.098 M | |
| Selling general and admin | 42.323 M | 41.798 M | 43.718 M | 44.634 M | 47.337 M | 45.964 M | 54.758 M | 52.909 M | |
| Research and development | 12.668 M | 40.548 M | 10.092 M | 13.289 M | 14.969 M | 17.499 M | 30.306 M | 22.189 M | |
| Total expenses | 73.912 M | 105.305 M | 80.695 M | 78.703 M | 87.314 M | 95.759 M | 128.216 M | 102.582 M | |
| 42.47% | -23.37% | -2.47% | 10.94% | 9.67% | 33.89% | -19.99% | |||
| Operating income | 33.116 M | 11.901 M | 47.613 M | 40.423 M | 46.902 M | 64.509 M | 40.196 M | 52.033 M | |
| Ebit | 33.116 M | 11.901 M | 47.613 M | 40.423 M | 46.902 M | 64.509 M | 40.196 M | 52.033 M | |
| Pretax income | 29.231 M | 7.967 M | 44.103 M | 37.780 M | 44.095 M | 51.832 M | 39.689 M | 51.785 M | |
| -72.74% | 453.57% | -14.34% | 16.72% | 17.55% | -23.43% | 30.48% | |||
| Income tax | 5.700 M | -79.976 M | -4.406 M | 8.295 M | 9.795 M | 13.371 M | 13.082 M | 13.451 M | |
| Net income basic | 23.531 M | 87.943 M | 48.509 M | 29.485 M | 34.300 M | 38.461 M | 26.607 M | 38.334 M | |
| 273.73% | -44.84% | -39.22% | 16.33% | 12.13% | -30.82% | 44.07% | |||
| Net income | 23.531 M | 87.943 M | 48.509 M | 29.485 M | 34.300 M | 38.461 M | 26.607 M | 38.334 M | |
| 273.73% | -44.84% | -39.22% | 16.33% | 12.13% | -30.82% | 44.07% |